Melanoma Clinical Trials

1973 clinical trials for Melanoma across international registries, including 285 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors — RECRUITING · PHASE1
• A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab — RECRUITING · PHASE2
• An open-label, mono-center study to evaluate the feasibility of fecal microbiota transplantation in modulating the frequency of CD8+ T-cells in peripheral blood of patients with melanoma — RECRUITING
• Natural History Study of Early Life Exposures in Agriculture (ELEA) — RECRUITING
• Harvesting Cells for Experimental Cancer Treatments — RECRUITING
• Timing of Immunotherapy in Melanoma — RECRUITING · NA
• Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers — RECRUITING · PHASE1
• Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma — RECRUITING
• A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer — RECRUITING · PHASE1
• Exercise and Nutritional Intervention in Patients With Melanoma Receiving Immunotherapy — RECRUITING · NA
• 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors — RECRUITING · NA
• A Study of MGC026 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC — RECRUITING · PHASE1
• Rural Adult and Youth Sun Protection Study — RECRUITING · NA
• Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma — RECRUITING · PHASE2
• Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization — RECRUITING · PHASE1
• A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE2
• Evaluation for NCI Surgery Branch Clinical Research Protocols — RECRUITING
• Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma — RECRUITING · NA
• Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies — RECRUITING
• Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App — RECRUITING
• Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment — RECRUITING
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection — RECRUITING
• IDOV-Immune for Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of GC101 TIL in Advanced Melanoma — RECRUITING · PHASE2
• Investigating Real-Time Immunotherapy Symptoms Study — RECRUITING · NA
• A Phase 2 Peri-operative Trial of Fianlimab and Cemiplimab Compared with Anti-PD1 Alone in Patients with Resectable Stage III and IV Melanoma — RECRUITING · PHASE2
• Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors — RECRUITING · PHASE1
• A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. — RECRUITING · PHASE1
• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas — RECRUITING · PHASE2
• Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) — RECRUITING · PHASE1
• Clinical Study on High-fiber Diet and Short-term Fasting in Melanoma Under Immunotherapy With Checkpoint Inhibition — RECRUITING · NA
• A Study of IBI363 in Subjects With Advanced Melanoma — RECRUITING · PHASE2
• Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management — RECRUITING
• MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors — RECRUITING · NA
• A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors — RECRUITING · PHASE1
• Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma. — RECRUITING · PHASE2
• Intratumoral N17350 in Advanced Solid Tumors — RECRUITING · PHASE1
• A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) — RECRUITING · PHASE3
• The Florida ASCENT Study — RECRUITING · NA
• A Study of BI 3810944 in Patients With Advanced Cancer — RECRUITING · PHASE1
• DESTINY-PANTUMOUR04 — RECRUITING
• Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors — RECRUITING · PHASE1
• Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials — RECRUITING · NA
• Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease — RECRUITING · PHASE1
• Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis — RECRUITING · PHASE1
• Safety and Efficacy of OBX-115 in Advanced Solid Tumors — RECRUITING · PHASE1
• Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases — RECRUITING · PHASE2
• Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients — RECRUITING · PHASE1
• Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors — RECRUITING · PHASE1

Refine this search